Cash for proof of concept
Tuesday, 11 November, 2008
A promising prostate cancer diagnostic test, bacteriophages to control salmonella in chickens and synthetic stretchy skin are the winners in a new round of proof-of-concept grants from the NSW Government.
Ten grants of up to $100,000 have been awarded to Sydney companies under the NSW Department of State and Regional Development’s BioBusiness proof-of-concept scheme.
Winners include Minomic, which is developing a proteomics-based urine test for prostate cancer; VetPhage, a company allied to Cellabs and Special Phage Services, which is developing bacteriophages for use in chickens bred for human consumption; and Elastagen, to produce a synthetic injectable form of tropoelastin for cosmetic and surgical applications.
Other winners include Human Genetic Signatures, which is developing a rapid diagnostic for MRSA; and Protech Research, which is developing enzyme technology to capture gluten lost in food processing.
Medical device companies NeuStent, Dosimetry and Imaging, E-Nose and Cellixe have also received grants.
Scientists uncover how cancer cells hide from immune system
By targeting the RNA helicase known as DDX6, scientists could enable the immune system to...
Vanillin flavouring in vapes may disrupt embryo development
Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
